BAY88-8223, Alpharadin, Breast Cancer Patients With Bone Dominant Disease

Clinical trial NCT01070485 · COMPLETED

Trial details

NCT number: NCT01070485
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Bone Metastases

Start date: 2010-01-01
Primary completion: 2011-03-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.